Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, September 15, 2023
Johnson & Johnson updated its brand and uniting both its medtech and pharmaceutical segments under the Johnson & Johnson brand name to demonstrate its collective power in healthcare.
read more
Friday, September 15, 2023
CordenPharma announced the inauguration of increased commercial peptide production capacity with newly-upgraded facilities at CordenPharma Colorado, the largest Solid-Phase Peptide Synthesis (SPPS) Manufacturing facility worldwide.
read more
Wednesday, September 13, 2023
Torx Software Limited, announces a collaboration with CDD Vault to facilitate the seamless synthesis and registration of new compounds during the small-molecule drug discovery process.
read more
Wednesday, September 13, 2023
Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, today announced the close of its £1.8M seed funding round, led by Mercia Ventures, and including ACF Investors, Ascension Ventures, o2h ...
read more
Wednesday, September 13, 2023
Devyser and Thermo Fisher Scientific entered an agreement to promote laboratory services. The goal is to partner with pharmaceutical companies to support their development projects utilising Devyser's unique assays in its CLIA-certified laboratory.
read more
Wednesday, September 13, 2023
Eisai announced that it has established a digital business company Theoria technologies which will accelerate the development of a dementia ecosystem. Theoria technologies is a wholly owned subsidiary of Eisai.
read more
Wednesday, September 13, 2023
Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), announced that it has received the cGMP Manufacturing Compliance Certificate, ...
read more
Tuesday, September 12, 2023
FibroBiologics, a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced the dedication of its cutting-edge laboratory ...
read more
Tuesday, September 12, 2023
Syneos Health® a biopharmaceutical solutions organization, announced a strategic collaboration that will expand its relationship with Oracle. Using the Oracle Cerner Learning Health Network (LHN) and elements of Oracle’s suite of study startup ...
read more
Monday, September 11, 2023
Orano Med SAS a biotechnology company developing Lead-212 (212Pb) Targeted Alpha Therapy against cancer, and Orbit Discovery Ltd, a developer of therapeutic peptide hits, announced that they have entered into a collaboration to discover specific ...
read more
Friday, September 08, 2023
Eminence Biotechnology (Suzhou) Co., Ltd. announced that its state-of-the-art facility for the commercial production of cell culture media is now fully operational.
read more
Thursday, September 07, 2023
Thermo Fisher Scientific Inc. and the National Minority Quality Forum (NMQF), an independent not-for-profit research and education organization, announced a collaboration to help bring clinical research to historically underserved patient populations...
read more
Wednesday, September 06, 2023
Clearmind Medicine Inc., a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced that the company has entered into a Clinical Trial Agreement with Johns ...
read more
Wednesday, September 06, 2023
XtalPi, a provider of AI-powered drug discovery solutions, and Parthenon Therapeutics, a clinical-stage biotechnology company dedicated to reprogramming the tumor microenvironment, announced a collaboration to discover novel therapeutic antibodies ...
read more
Friday, September 01, 2023
Twist Bioscience Corporation , a provider of high-quality synthetic DNA using its silicon platform, announced a drug discovery agreement with Ono Pharmaceutical Co., Ltd. (to discover and develop novel antibodies for the treatment of autoimmune ...
read more